(c).
| Variable | Group | RTE (CI) | ||
|---|---|---|---|---|
| Pre | Post | 3 h | ||
| AAT | EET | 0.55 (0.45; 0.65) | 0.59 (0.48; 0.68) | 0.66 (0.56; 0.74) |
| SED$$ | 0.35 (0.27; 0.43) | 0.35 (0.25; 0.47) | 0.46 (0.38; 0.55)∗∗ | |
|
| ||||
| CA-125 | EET | 0.48 (0.38; 0.59) | 0.74 (0.63; 0.81)∗∗∗ | 0.52 (0.42; 0.61) |
| SED$ | 0.38 (0.29; 0.48) | 0.52 (0.42; 0.62)∗ | 0.33 (0.25; 0.44) | |
|
| ||||
| CD40 | EET | 0.50 (0.4; 0.6) | 0.68 (0.59; 0.76)∗∗∗ | 0.59 (0.49; 0.68)∗ |
| SED$ | 0.38 (0.29; 0.49) | 0.44 (0.33; 0.55) | 0.38 (0.28; 0.49) | |
|
| ||||
| GH | EET | 0.37 (0.31; 0.43) | 0.85 (0.81; 0.87)∗∗∗ | 0.45 (0.4; 0.51)∗ |
| SED$$ | 0.22 (0.17; 0.29) | 0.79 (0.74; 0.83)∗∗∗ | 0.29 (0.22; 0.39)∗ | |
|
| ||||
| Insulin | EET | 0.57 (0.48; 0.65) | 0.30 (0.23; 0.39)∗∗∗ | 0.42 (0.31; 0.53)∗ |
| SED$ | 0.71 (0.59; 0.8) | 0.46 (0.34; 0.58)∗∗ | 0.57 (0.45; 0.68) | |
|
| ||||
| IL-3 | EET | 0.63 (0.54; 0.71) | 0.62 (0.53; 0.7) | 0.68 (0.59; 0.75) |
| SED$$$ | 0.34 (0.26; 0.44) | 0.31 (0.23; 0.4) | 0.37 (0.29; 0.46) | |
|
| ||||
| IL-7 | EET | 0.59 (0.5; 0.67) | 0.62 (0.53; 0.69) | 0.66 (0.57; 0.74)∗∗ |
| SED$$ | 0.36 (0.27; 0.47) | 0.34 (0.26; 0.44) | 0.39 (0.3; 0.48) | |
|
| ||||
| IL-8 | EET | 0.48 (0.39; 0.58) | 0.73 (0.66; 0.79)∗∗∗ | 0.56 (0.46; 0.64) |
| SED$$ | 0.33 (0.23; 0.45) | 0.53 (0.41; 0.63)∗∗ | 0.34 (0.26; 0.43) | |
|
| ||||
| IL-10 | EET | 0.37 (0.29; 0.46) | 0.81 (0.74; 0.86)∗∗∗ | 0.56 (0.46; 0.65)∗∗ |
| SED$$ | 0.32 (0.24; 0.41) | 0.56 (0.45; 0.65)∗∗ | 0.36 (0.27; 0.46) | |
|
| ||||
| IL-13 | EET | 0.60 (0.51; 0.69) | 0.55 (0.46; 0.64) | 0.63 (0.53; 0.71) |
| SED$ | 0.39 (0.3; 0.49) | 0.38 (0.29; 0.48) | 0.42 (0.32; 0.52) | |
|
| ||||
| MCP-1 | EET | 0.52 (0.42; 0.61) | 0.77 (0.69; 0.83)∗∗∗ | 0.48 (0.4; 0.57) |
| SED$$ | 0.28 (0.21; 0.37) | 0.57 (0.44; 0.69)∗∗∗ | 0.35 (0.25; 0.47) | |
|
| ||||
| Myoglobin | EET | 0.27 (0.21; 0.35) | 0.58 (0.51; 0.64)∗∗∗ | 0.79 (0.74; 0.82)∗∗∗ |
| SED$ | 0.17 (0.14; 0.23) | 0.41 (0.33; 0.50)∗∗∗ | 0.76 (0.66; 0.83)∗∗∗ | |
|
| ||||
| TNF-α | EET | 0.56 (0.47; 0.64) | 0.64 (0.55; 0.71)∗ | 0.56 (0.47; 0.65) |
| SED$ | 0.40 (0.3; 0.51) | 0.44 (0.35; 0.53) | 0.38 (0.29; 0.48) | |
|
| ||||
| TNFR2 | EET | 0.54 (0.45; 0.63) | 0.74 (0.65; 0.8)∗∗∗ | 0.60 (0.52; 0.68) |
| SED$$$ | 0.32 (0.24; 0.42) | 0.38 (0.31; 0.47) | 0.36 (0.28; 0.45) | |
|
| ||||
| VCAM-1 | EET | 0.53 (0.44; 0.63) | 0.66 (0.57; 0.73)∗ | 0.60 (0.51; 0.69) |
| SED$ | 0.33 (0.26; 0.42) | 0.41 (0.32; 0.51)∗ | 0.43 (0.34; 0.53)∗ | |
AAT = alpha-1-antitrypsin; CA-125 = Cancer Antigen 125; CD40 = CD 40 antigen; GH = growth hormone; IL-3 = interleukin-3; IL-7 = interleukin-7; IL-8 = interleukin-8; IL-10 = interleukin-10; IL-13 = interleukin-13; MCP-1 = monocyte chemotactic protein-1; TNF-α = tumor necrosis factor-alpha; TNFR2 = tumor necrosis factor receptor 2; VCAM-1 = Vascular Cell Adhesion Molecule-1.